Clinical Trials Browser

Phase 1/2 × Pelvic Neoplasms × Immunotherapy, Adoptive × Clear all

NCT03757858 2024-02-07

Hyperthermia Combined With Immunotherapy in the Treatment of Abdominal and Pelvic Malignancies or Metastases

Phase 1/2 Completed

Neoplasm Metastasis, Neoplasms, Pelvic Neoplasms